mounjaro tirzepatide werking for Weight Loss Mounjaro (tirzepatide) for the Treatment

Study author Patricia Rodriguez, PhD, MPH, principal applied scientist at Truveta, which partly funded the study, noted the following additional highlights of the studys findings, to MNT : Patients on tirzepatide were over two times more likely to experience 10% weight loss and three times more likely to experience 15% weight loss within a year, compared to patients on semaglutide

Early phase 2 research showed participants losing up to 24.2% of their body weight after 48 weeks

Had to take more than the recommended dosage

Zepbound is not licensed as a weight loss product in the UK

However, the BUD assigned by the pharmacy already accounts for the complete formulation, including any additives

Reduces Appetite: GLP-1 acts on the brain to decrease appetite and increase feelings of satiety, which can lead to weight loss